| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	
 
																	UBS analyst Kevin Caliendo maintains Dentsply Sirona (NASDAQ:XRAY) with a Buy and lowers the price target from $24 to $23.
 
																	
 
																	On October 14, 2025, DENTSPLY SIRONA Inc. (the "Company") announced that the Division of Enforcement of the Securities ...
 
																	Evercore ISI Group analyst Elizabeth Anderson maintains Dentsply Sirona (NASDAQ:XRAY) with a In-Line and lowers the price ta...
 
																	
 
																	In the last three months, 5 analysts have published ratings on Dentsply Sirona (NASDAQ: XRAY), offering a diverse range of pers...
 
																	Needham analyst David Saxon reiterates Dentsply Sirona (NASDAQ: XRAY) from Hold to Hold.
 
																	DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company has co...